Stop tuberculosis: bottom-line benefits
Evidence on the economic benefits of tuberculosis (TB) diagnosis and treatment was reported by the World Bank, WHO and the Stop TB Partnership in December. Forecasters said that therapy would more than pay for itself in the worst-hit countries, when the financial impact of TB illnesses is compared to the costs of diagnosis and treatment. The good news follows the WHO Global Tuberculosis Control Report in March that found the percentage of the world's population struck by TB levelling off. A strong link between HIV/AIDS and deaths from TB and drug-resistant strains of TB is a key barrier to further progress.